1. Home
  2. UFPT vs XERS Comparison

UFPT vs XERS Comparison

Compare UFPT & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFPT
  • XERS
  • Stock Information
  • Founded
  • UFPT 1963
  • XERS 2005
  • Country
  • UFPT United States
  • XERS United States
  • Employees
  • UFPT N/A
  • XERS N/A
  • Industry
  • UFPT Medical/Dental Instruments
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UFPT Health Care
  • XERS Health Care
  • Exchange
  • UFPT Nasdaq
  • XERS Nasdaq
  • Market Cap
  • UFPT 1.6B
  • XERS 1.3B
  • IPO Year
  • UFPT 1993
  • XERS 2018
  • Fundamental
  • Price
  • UFPT $234.49
  • XERS $9.87
  • Analyst Decision
  • UFPT Buy
  • XERS Strong Buy
  • Analyst Count
  • UFPT 2
  • XERS 7
  • Target Price
  • UFPT $289.00
  • XERS $9.43
  • AVG Volume (30 Days)
  • UFPT 128.6K
  • XERS 2.3M
  • Earning Date
  • UFPT 11-03-2025
  • XERS 11-06-2025
  • Dividend Yield
  • UFPT N/A
  • XERS N/A
  • EPS Growth
  • UFPT 23.11
  • XERS N/A
  • EPS
  • UFPT 8.61
  • XERS N/A
  • Revenue
  • UFPT $597,952,000.00
  • XERS $246,025,000.00
  • Revenue This Year
  • UFPT $21.64
  • XERS $43.89
  • Revenue Next Year
  • UFPT $6.29
  • XERS $20.40
  • P/E Ratio
  • UFPT $27.24
  • XERS N/A
  • Revenue Growth
  • UFPT 29.47
  • XERS 35.62
  • 52 Week Low
  • UFPT $178.26
  • XERS $2.82
  • 52 Week High
  • UFPT $354.22
  • XERS $10.08
  • Technical
  • Relative Strength Index (RSI)
  • UFPT 70.32
  • XERS 72.15
  • Support Level
  • UFPT $182.87
  • XERS $9.48
  • Resistance Level
  • UFPT $263.40
  • XERS $9.97
  • Average True Range (ATR)
  • UFPT 11.39
  • XERS 0.38
  • MACD
  • UFPT 3.69
  • XERS 0.04
  • Stochastic Oscillator
  • UFPT 64.10
  • XERS 81.34

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: